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Detrimental role of the airway mucin Muc5ac
during ventilator-induced lung injury
M Koeppen1,2, EN McNamee1, KS Brodsky1, CM Aherne1, M Faigle3, GP Downey4,5, SP Colgan6,
CM Evans5, DA Schwartz5 and HK Eltzschig1
Acute lung injury (ALI) is associated with high morbidity and mortality in critically ill patients. At present, the functional
contribution of airwaymucins to ALI is unknown.We hypothesized that excessivemucus production could be detrimental
during lung injury. Initial transcriptional profiling of airway mucins revealed a selective and robust induction of MUC5AC
upon cyclic mechanical stretch exposure of pulmonary epithelia (Calu-3). Additional studies confirmed time- and stretch-
dose-dependent induction of MUC5AC transcript or protein during cyclic mechanical stretch exposure in vitro or during
ventilator-induced lung injury in vivo. Patients suffering from ALI showed a 58-fold increase in MUC5AC protein in their
bronchoalveolar lavage. Studies of the MUC5AC promoter implicated nuclear factor jB in Muc5ac induction during ALI.
Moreover, mice with gene-targeted deletion of Muc5ac / experience attenuated lung inflammation and pulmonary
edema during injurious ventilation. We observed that neutrophil trafficking into the lungs of Muc5ac / mice was
selectively attenuated. This implicates that endogenous Muc5ac production enhances pulmonary neutrophil trafficking
during lung injury. Together, these studies reveal a detrimental role for endogenous Muc5ac production during ALI and
suggest pharmacological strategies to dampen mucin production in the treatment of lung injury.
INTRODUCTION
Acute lung injury (ALI) is a life-threatening disorder that can
develop in the course of different clinical conditions such as
pneumonia, acid aspiration, major trauma, or prolonged
mechanical ventilation and contributes significantly to critical
illness.1 For example, epidemiological studies show that each
year 75,000 patients in the United States alone die from acute
respiratory distress syndrome, a severe form of ALI.2 The
pathogenesis of ALI is characterized by the influx of a protein-
rich edema fluid into the interstitial and intra-alveolar spaces as
a consequence of increased permeability of the alveolar–
capillary barrier1 in conjunction with excessive invasion of
inflammatory cells—particularly polymorphonuclear leuko-
cytes (PMNs).3–6 Indeed, several experimental and clinical
studies indicate that pulmonary PMN accumulation represents
a key event in the pathophysiology of ALI. For example,
depletion of PMNs can curb experimental lung damage,7 while
lung function in patients suffering from ALI negatively
correlates with neutrophil counts in the blood,8 and persisting
pulmonary neutrophilia is correlated with poor outcome.9
Mucosal surfaces—such as the airway epithelia—have a
protective mucus barrier. For example, airway mucus traps
inhaled toxins and transports them out of the lungs bymeans of
ciliary beating and cough. Airway mucus is a mixture of water,
cells, cellular debris, andmucins—heavy glycoproteins—which
represent the major protein component of mucus.10 The two
predominant mucins of the human airway are MUC5AC and
MUC5B.10 In healthy lungs, MUC5AC is produced predo-
minantly in the tracheobronchial secretory cells at the airway
surface, whereas MUC5B is produced in surface secretory cells
throughout the airways and by submucosal glands.10–14 In the
airways of normal mice, almost no Muc5ac is produced,10,15
and mice with Muc5ac deletion appear to be healthy.16 By
contrast, Muc5b is produced constitutively in airway surface
secretory cells,10,15,17 and it remains abundant in lung
inflammation. Although a deficient mucous barrier intuitively
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leaves the lungs vulnerable to injury, excessive mucus or
impaired clearance contributes to the pathogenesis of common
airway diseases, such as cystic fibrosis, pulmonary fibrosis,
asthma, and chronic obstructive pulmonary disease.11,18,19
Despite of the fact thatmany previous studies have addressed
the functional role ofmucins in lung disease, essentially nothing
is known about the specific functions of airway mucins during
ALI. In the context of previous studies showing that ALI
provides strong transcriptional stimuli,20–22 and other studies
implicating transcriptionally controlled pathways in the
regulation of the airway mucin production,14,23,24 we pursued
the expression patterns of airway mucins in a microarray study
of airway epithelia (Calu-3) exposed to cyclic mechanical
stretch. These microarray studies revealed a selective induction
of MUC5AC with stretch conditions. Surprisingly, subsequent
studies in genetic models indicate that the endogenous
production of Muc5ac induced by mechanical ventilation
has a detrimental role during ALI. In line with previous studies
indicating that PMN contribute to tissue injury during ALI, we
observed that genetic deletion ofMuc5ac was associated with a
selective attenuation of PMNs during experimental lung injury.
RESULTS
Microarray studies of human pulmonary epithelia exposed
to cyclic mechanical stretch reveal selective induction of
MUC5AC
Mucins are an integral part of the innate defense system of
the lung, and they have been implicated in various lung
diseases, including chronic obstructive pulmonary disease,
cystic fibrosis, and asthma.10,19,25–27 However, their functional
role in ALI remains largely unknown. Mucin production
is regulated on a transcriptional level.14,23 Therefore, we
performed profiling studies of mucin mRNA levels utilizing
human pulmonary epithelial cells exposed to cyclic mechanical
stretch as an in vitro model of ventilator-induced lung injury
(VILI). The findings from thismicroarray revealed a robust and
selective induction of MUC5AC (22.6±4.1 fold vs. control;
n¼ 2; Po0.05), whereas all other airway mucins were either
unchanged or suppressed (Figure 1). Based on these findings,
we further pursued a potential functional role of MUC5AC
during ALI.
MUC5AC transcript and protein levels are induced
with cyclic mechanical stretch in vitro
After having shown a selective induction of MUC5AC in
microarray studies of pulmonary epithelia exposed to cyclic
mechanical stretch, we next investigated the time course of
MUC5AC induction in different model cell lines of airway
epithelia.We submitted Calu-3 or A549 pulmonary epithelia to
various durations of cyclic mechanical stretch and found a
time-dependent induction of MUC5AC transcript and protein
release into the supernatant (Figure 2a–d). Taken together with
our above microarray studies, these findings indicate that
MUC5AC transcript and protein levels are increased during
conditions of cyclic mechanical stretch as occurs in the setting
of mechanical ventilation.
MUC5AC expression is increased in mice exposed to VILI
Based on our in vitro findings showing MUC5AC induction
during cyclic mechanical stretch of pulmonary epithelia, we
next pursued studies of Muc5ac expression during murine
VILI. We anesthetized mice and performed a tracheostomy,
followed by pressure-controlled ventilation with an inspiratory
pressure level of 45mbar over indicated time periods
(0–3 h).20,28–30 Consistent with the in vitro findings,
we observed a robust induction of the Muc5ac transcript
in response to high-pressure ventilation (Figure 2e; Po0.005).
By contrast, transcript levels for Muc2 were unaltered, whereas
Muc5b transcript was significantly repressed during VILI (see
Supplementary Figure S1 online). Utilizing immunofluore-
scence microscopy, we also observed induction of Muc5ac
protein in mice exposed to VILI over 3 h (Figure 2f). Control
studies in previously described mice gene-targeted for
Muc5ac16 provide specificity for these staining studies
(Figure 2f). Taken together, these studies indicate
induction of MUC5AC transcript and protein levels during
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Figure 1 Transcriptional alteration of human pulmonary epithelial
mucins in response to cyclic-mechanical stretch. Calu-3 human
pulmonary were plated on collagen-coated plates and underwent cyclic
mechanical stretch at 20% stretch maximum, 0.7% stretch minimum, sine
wave 2 s, on 2 s off for 18 h or were maintained at rest. Total RNA was
isolated and the transcriptional changeswere analyzed using amicroarray
technique (accession number: GSE34789). Mucins that were previously
shown to be expressed in the airway are shown. Results are expressed as
fold change in relation to baseline expression. Note: selective induction of
Muc5ac in response to cyclic-mechanical stretch (Po0.0001, n¼ 3).
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cyclic mechanical stretch exposure of human airway epithelia
in vitro or during murine VILI in vivo.
MUC5AC protein is increased in patients with ALI
Having demonstrated that MUC5AC is induced in models of
ALI, we examined MUC5AC protein levels in patients with ALI.
After approval by the Internal ReviewBoard, lavage sampleswere
collected in patients experiencing ALI or corresponding healthy
controls (see Supplementary Table S1 online). We
retrospectively measured MUC5AC protein levels in the
lavage fluid collected from unventilated control subjects or
patients diagnosed with ALI utilizing enzyme-linked immuno-
sorbent assay (ELISA). Interestingly, these studies revealed a 58.8-
fold increase of MUC5AC protein in the BAL fluid of patients
with ALI. These novel findings indicate that MUC5AC is
increased in the BAL fluid of humans experiencing ALI.
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Figure 2 MUC5AC transcript and protein levels during cyclic mechanical in vitro or during acute lung injury in vivo. (a) Calu-3 human pulmonary
epithelial cells were submitted to cyclic mechanical stretch. After the indicated time points total RNAwas isolated and sampleswere probed forMUC5AC
mRNA levels by reverse transcriptase–PCR (RT-PCR). Transcriptional changes were calculated relative to an internal housekeeping gene (b-actin).
Data are expressed as mean fold change±s.d. compared with 0 h cyclic mechanical stretch (n¼ 4). (b) Supernatants from stretched Calu-3 human
pulmonary epithelia were collected at indicated time points and probed for MUC5AC protein by enzyme-linked immunosorbent assay (ELISA). Data are
expressed asmean fold change±s.d. compared with 0 h cyclic mechanical stretch (n¼ 4). (c) A549 human pulmonary epithelial cells were submitted to
cyclic mechanical stretch. After the indicated time points, total RNA was isolated, and samples were probed for MUC5AC mRNA levels by RT-PCR.
Transcriptional changes were calculated relative to the internal housekeeping gene (b-actin). Data are expressed as mean fold change±s.d. compared
with 0 h cyclic mechanical stretch (n¼ 4). (d) Supernatants from stretched A549 human pulmonary epithelia were collected at indicated time points and
probed for MUC5AC protein by ELISA. Data are expressed asmean fold change±s.d. compared with 0 h cyclic mechanical stretch (n¼4). (e) C57BL/6
mice were mechanically ventilated (inspiratory pressure (Pinsp) 45mbar, 100% oxygen). After indicated time periods, lungs were harvested; total RNA
isolated, andMuc5acmRNA levels were determined by real-time RT-PCR. Data are calculated relative to the internal housekeeping gene (b-actin) and
are expressed asmean fold change compared with control (0 h ventilation)±s.d. (n¼4). (f)Muc5ac / or corresponding littermate controls matched in
age, sex, and weight (Muc5aþ /þ mice) weremechanically ventilated (inspiratory pressure 45mbar, inspired oxygen fraction 1.0, positive-end expiratory
pressure 3mbar). After 3 h of mechanical ventilation, the lungs were fixated in situ and stained with antibodies for Muc5ac. Immunoglobulin G controls
were used at identical concentrations and staining conditions as the target primary antibodies. One representative experiment out of four is shown
(original magnification  400). VILI, ventilator-induced lung injury.
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Nuclear factor (NF-jB) is critical for MUC5AC induction
during cyclic mechanical stretch in vitro or during
ALI in vivo
After having shown thatMUC5AC is induced inmodel systems
of lung injury or in patients suffering from ALI, we next
analyzed the transcriptional mechanism governing MUC5AC
expression under these conditions. Previous studies had
implicated NF-kB in the transcriptional regulation of
MUC5AC23 and that this is mediated via binding of NF-kB
to a specific area within the MUC5AC promoter (Figure 4a).31
Indeed, during similar conditions of cyclic mechanical stretch
associated with the transcriptional induction of MUC5AC, we
observed robust increases of NF-kB reporter activity (3.8-fold
increase; Figure 4b; Po0.0001). To examine the influence
of cyclic mechanical stretch conditions on the MUC5AC
promoter, we cloned the previously described human
MUC5AC promoter31 into a PGL4-vector and examined
alterations in promoter activity with stretch conditions. Cells
transiently transfected with the wild-type promoter showed a
2.4±0.1-fold increase in promoter activity when exposed to
cyclic mechanical stretch as compared with unstretched
controls. By contrast, stretch-responsiveness of a promoter
construct with a mutated, putative NF-kB binding site was
completely lost, implicating a functional role of NF-kB binding
to the MUC5AC promoter during cyclic mechanical stretch
(Figure 4c).
As second line of evidence, we inhibited NF-kB pharma-
cologically with a highly selective inhibitor, IKK-16.32 For this
purpose, IKK-16 (3 mM) was added to the supernatants of
Calu-3 cells 2 h before stretch exposure.32 Subsequently, we
examined MUC5AC transcript levels at indicated time points
in the IKK-16-treated cells or controls treated with vehicle.
Indeed, pharmacological inhibition of NF-kB activation with
IKK-16 completely abolished the induction of MUC5AC
transcript levels during cyclic mechanical stretch exposure
(Figure 4d). Similarly, IKK-16 treatment abolished the
induction of MUC5AC protein levels in stretch-exposed
Calu-3 cells (Figure 4e).
We next extended these findings into in vivo studies of ALI
induced bymechanical ventilation. Based onprevious studies,32
we pretreated BL6 mice 30min before the induction of VILI
with IKK-16 (30mg kg 1) or vehicle control. Following 3 h of
exposure to VILI (pressure-controlled ventilation at 45mbar),
we examined Muc5ac transcript levels by real-time reverse
transcriptase–PCR.Consistent with the inhibition ofMUC5AC
induction during cyclic mechanical stretch in vitro, in vivo
treatment with IKK-16 abrogated Muc5ac induction
(Figure 4f). Taken together these studies collectively
suggest that NF-kB directly regulates MUC5AC induction
during cyclic mechanical stretch in vitro or during murine lung
injury induced by mechanical ventilation in vivo.
Muc5ac / mice are protected during VILI
Having shown that the transcriptional control of MUC5AC
during ALI involves NF-kB, we next examined the functional
role of Muc5ac during VILI. For this purpose, we
subjected recently described Muc5ac gene-targeted mice16
to VILI (pressure-controlled ventilation at 45mbar for 3 h) and
measured the extent of ALI. Surprisingly, the profound
reduction of pulmonary gas exchange (ratio of the arterial
oxygen pressure (PaO2) to the fraction of inspired oxygen
(FiO2)) observed in wild-type mice was almost completely
abolished in Muc5ac–/– mice. This provides the first evidence
for a detrimental role of Muc5ac in ALI (Figure 5a).
Furthermore, we found that ALI-induced increases in
pulmonary edema assessed by albumin leakage into the
BAL or measurements of lung water content were
significantly lower in Muc5ac-deficient mice (Figure 5b,c).
As next step, we performed histological studies to examine
whether VILI was associated with a more pronounced
obstruction of small airways. However, no mucous plugs or
difference in the number of mucous-producing cells were
observed in Muc5acþ /þ or Muc5ac / (Figure 5d).
Assessment of pulmonary histology following VILI revealed
a significantly lower degree of histological tissue injury in
Muc5ac–/– mice compared with littermate controls
(Figure 5d,e). Moreover, Muc5ac–/– mice survived
significantly longer when submitted to VILI than wild-type
littermate controls (Figure 5f). Together these studies provide
the first genetic evidence for improved pulmonary function and
decreased severity of VILI associated with genetic deletion of
Muc5ac.
Muc5ac enhances pulmonary inflammation in ALI
Previous studies strongly implicated an excessive invasion of
inflammatory cells (particularly PMNs) in the pathogenesis of
ALI.3–6 Therefore, we examined inflammatory end points in
Muc5ac / mice or littermate controls exposed to VILI. First,
we quantified the myeloperoxidase (MPO) as a readout for
PMN tissue accumulation33 in lung homogenates following 3 h
of mechanical ventilation at 45mbar. Consistent with previous
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Figure 3 MUC5AC content in the bronchoalveolar lavage (BAL) of
patients with acute lung injury (ALI). Human BAL fluid was obtained from
patients with ALI and MUC5AC protein content was assessed using
enzyme-linked immunosorbent assay. Results were compared with
samples collected fromunventilated subjectswithout lung injury,whowere
otherwise healthy. Results are presented asmean±s.d. (n¼ 5per group).
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studies, we found profound increase in pulmonary MPO
following the induction of ALI in wild-type animals.20–22 By
remarkable contrast, however, this increase in pulmonaryMPO
levels was almost completely abolished in Muc5ac / mice
(Figure 6a). We found similar alterations of inflammatory end
points for Cxcl1 transcript (Figure 6b) and protein (Figure 6c),
Cxcl2 transcript (Figure 6d) and interleukin (IL)-6 protein
(Figure 6e), indicating that genetic deletion of Muc5ac is
associated with an attenuated acute inflammatory response
during VILI.
To further define the role of Muc5ac in the inflammatory
response during VILI, we performed a PCR array to examine
the expression levels of various cytokines and their receptors in
Muc5ac / mice or corresponding littermate controls.
Following VILI (45mbar over 3 h), many proinflammatory
cytokines were induced in wild-type or Muc5ac / mice
(see Supplementary Table S3 online). However, several
chemokines and chemokine receptors implicated in PMN
trafficking were differentially regulated. Their transcriptional
induction was significantly less pronounced in Muc5ac /
mice when compared with wild-type animals (e.g., Ccl20, Ccl7,
Cxcl1 and Cxcl10 and Il-11; see Supplementary Table S4
online). Taken together, these studies suggest thatMuc5ac /
mice experience attenuated lung inflammation and neutrophil
trafficking during VILI.
Muc5ac deletion selectively dampens pulmonary
neutrophil accumulation during VILI
Muc5ac / mice experienced attenuated lung inflammation
during VILI. This was in conjunction with attenuated
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Figure 4 Transcriptional regulation of Muc5ac during cyclic mechanical stretch in vitro or during acute lung injury in vivo. (a) Upper panel:
Schematic of human MUC5AC promoter. Middle panel: Core sequence of the nuclear factor (NF)-kB binding site of the human MUC5AC
promoter located 217 to 229 bp upstream from the transcription start site (TSS). Lower panel: Loss of function mutation of NF-kB binding site in
MUC5AC promoter construct studies. (b) Luciferase activity in A549 pulmonary epithelial cells transfected with a firefly luciferase reporter plasmid for
NF-kBand renilla luciferase reporter plasmids.Cellswere exposed to24 hof cylicmechanical stretch andall activitywas normalizedwith respect to renilla
reporter. Results are presented as ‘‘fold change’’ in luminescence relative to that of an empty PGL-luciferase. Data were calculated as fold
change compared with 0 h cyclic mechanical stretch and are expressed as mean±s.d. (n¼ 4). (c) Luciferase activity in A549 pulmonary epithelial
cells transfected with human MUC5AC promoter firefly luciferase reporter construct or renilla luciferase reporter plasmid, then exposed to 24 h of cyclic
mechanical stretch. Full-lengthMUC5AC promoter (1,000 bp upstream of TSS);DNF-kB loss-of-functionmutation of NF-kB binding site (position 229
to 217 relative to TSS). Data were calculated as fold change compared with 0 h cyclic mechanical stretch and are expressed as mean±s.d. (n¼ 4).
(d) Calu-3 human pulmonary epithelial cells were incubated with the NF-kB-inhibitor IKK-16 followed by cylic mechanical stretch and harvested at the
indicated time points. Total RNAwas isolated, and samples were probed. MUC5ACmRNA by reverse transcriptase–PCR (RT-PCR) and transcriptional
changes were calculated relative to the internal housekeeping gene (b-actin). Data are expressed as mean fold change compared with 0 h of cyclic
mechanical stretch±s.d. (n¼6). (e) Calu-3 human pulmonary epithelial cells were incubated with the NF-kB-inhibitor IKK-16 followed by cyclic
mechanical stretch and harvested at the indicated time points. Cell lysates were probed for MUC5AC protein levels by enzyme-linked immunosorbent
assay. Data are expressed as mean fold change compared with 0 h of cyclic mechanical stretch±s.d. (n¼ 6). (f) C57BL/6 mice were treated with
30mg kg1 IKK-16 (NF-kB-inhibitor) followed by mechanical ventilation (inspiratory pressure 45mbar, inspired oxygen fraction 1.0, positive-end
expiratory pressure 3mbar). After 3 h, lungs were harvested; total RNA isolated, and Muc5ac mRNA levels were determined by real-time RT-PCR.
Data were calculated relative to the internal housekeeping gene (b-actin) and are expressed as mean fold change compared with control
(0 h ventilation)±s.d. (n¼ 4).
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expression of pulmonary chemokines and chemokine
receptors implicated in PMN trafficking. Subsequently, we
analyzed influence of Muc5ac gene-deletion on myeloid cell
trafficking during VILI. We submitted Muc5ac / mice or
corresponding littermate controls to VILI (45mbar inspiratory
pressure, 3 h), harvested lung tissue and BAL fluid and
performed flow cytometry on live leukocytes (CD45þ cells).
Consistent with the PCR array showing a selective increase of
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Figure 5 Phenotypic characterization of Muc5ac / mice during ventilator-induced lung injury (VILI). (a–f) Muc5ac / mice or corresponding
littermate controls matched in age, sex, and weight (Muc5aþ /þ ) were mechanically ventilated (inspiratory pressure (Pinsp) 45mbar, inspired oxygen
fraction (FiO2) 1.0, positive-end expiratory pressure 3mbar). (a) Arterial blood samples were collected at indicated time points and analyzed for oxygen
partial pressure (PaO2) by a bedside blood gas analyzer. Ratio of PaO2 and FiO2 was calculated. Data are shown as mean±s.d. (n¼6 per group). (b)
Bronchoalveolar lavage (BAL) fluidwas collected at the indicated timepoints andwasanalyzed for albumin content. Data are shownasmean±s.d. (n¼ 6
per group). (c) At indicated time points, lungs were excised, patted dry, and weighed. Then lungs were dried for 48 h, and lung water content (mg lung
water per mg dry tissue) was determined. Data are shown as mean±s.d. (d) Muc5ac / or corresponding littermate controls were mechanically
ventilated as described above. Lungs were fixed in situ and stained with hematoxylin and eosin (H&E). (original magnification  40; n¼ 4). (e) For
quantification of tissue damage due tomechanical ventilation, a histological score for VILI was assessed inMuc5acþ /þ andMuc5ac / mice based on
H&E stainings. Results are displayed as median±s.d. (n¼5). (f) Muc5ac / or corresponding littermate controls were mechanically ventilated as
described above until a cardiac standstill was observed in the surface electrocardiogram. (n¼ 5).
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trafficking markers for PMN, Ly6Ghigh/CD11bhigh cells (PMN)
were selectively increased in the pulmonary tissue of wild-type
mice exposed to VILI (Figure 7a–d). By contrast, this increase
in pulmonary PMN accumulation was completely abolished in
lungs fromMuc5ac / mice. Granulocyte trafficking into the
BAL (Figure 7e–h) mirrored the studies of lung tissue,
confirming that Muc5ac / mice experience a selective
attenuation of PMN trafficking into the alveolar airspace
during ALI induced by mechanical ventilation.
Muc5ac enhances neutrophil transmigration in vitro
Studies of granulocyte trafficking into the lungs during VILI
indicated a selective attenuation of PMN transmigration into
lung tissue and BAL of Muc5ac / mice. We next pursued
in vitro studies of PMN transmigration. For this purpose, we
examined the effect of supernatants from stretch-exposed
control cells or small interfering RNA (siRNA)-mediated
MUC5AC-deficient cells on PMN transmigration. Human
pulmonary epithelia (Calu-3) were transfected with stable
siRNA to repress MUC5AC. As shown in Figure 8a, hairpin
siRNA-mediatedMUC5AC repression significantly attenuated
MUC5AC transcript and protein levels in Calu-3 cells in
comparison to control-siRNA-transfected Calu3 cells
(Figure 8a). To examine the functional role of MUC5AC
release into the supernatant, we submitted thesemodel cell lines
to 24 h cyclic mechanical stretch. Subsequently, we harvested
the supernatant of stretched cells or unstretched controls and
transferred the supernatant to the basal compartment of a PMN
transmigration chamber. We then added freshly isolated
human PMN to the apical compartment of the chamber
(Figure 8b). PMN transmigration towards a chemotactic agent
(formyl-methinyl-leucyl-phenylalanine) was carried out across
a mechanical barrier (inserts with a pore size of 3 mm2;
Figure 8c) or a biological barrier (Calu-3 pulmonary epithelia
grown to confluence, Figure 8d). Indeed, assessment of
PMN transmigration by measuring MPO from the basal
compartment revealed that stretch-exposed supernatants from
control-transfected cells significantly increased PMN
transmigration in both the models. By contrast,
supernatants from MUC5AC-deficient cell lines had no
significant effect on PMN transmigration. Taken together,
these studies suggest that endogenous induction of MUC5AC
enhances in vitro transmigration of PMN.
Muc5ac contributes to chemotactic trafficking of PMNs into
the lungs in vivo
The above studies implicated thatMUC5AC secretion interacts
with PMN transmigration in vitro. We extended these findings
into an in vivo model of pulmonary PMN trafficking.
Muc5ac / mice or littermate controls underwent 3 h of
mechanical ventilation. We assumed that this treatment is
associated with the production and release of Muc5ac in
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total protein content of homogenate determinedbybicinchoninic acid assay (BCA).Dataare expressedasmean±s.d. (n¼ 5). (b) TotalRNAwas isolated
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wild-type but not in Muc5ac / mice. Subsequently, we
harvested 500 ml of BAL and eliminated any cellular content
by centrifugation. Next, wild-type mice were anesthetized,
intubated, and 100 ml of freshly harvested BAL fluid was
instilled into their lungs via the endotracheal tube (Figure 9a).
After an additional 3 h of gentle mechanical ventilation at
15mbar, animals were killed and pulmonary granulocyte
trafficking was assessed by flow cytometry. Surprisingly, these
studies revealed that transfer of BAL from mechanically
ventilated Muc5acþ /þ mice into Muc5acþ /þ was
associated with a substantial and selective increase in neutro-
phil numbers into the BAL (Figure 9b) and lung tissue
(Figure 9c). Where we transferred BAL from ventilated
Muc5ac / mice into wild-type mice, this increase in
PMN numbers was almost completely abolished. Taken
together these data suggest that Muc5ac increase PMN
trafficking into the lungs during ALI.
DISCUSSION
ALI significantly contributes to critical illness, as it occurs
frequently2 and carries a high mortality rate.1 Moreover, the
only therapeutic interventions currently available are elimina-
tion of the causative agents and supportive therapy.1 Although
airwaymucins have previously been implicated inmany airway
diseases, including asthma, chronic obstructive pulmonary
disease, and pulmonary fibrosis,10,19,25,26,34 their functional
roles during ALI are essentially unknown. Our studies revealed
a selective and robust induction of the human airway mucin
MUC5AC. Similarly, patients experiencing ALI showed
elevated MUC5AC levels in their BAL fluid (58-fold increase).
Moreover, Muc5ac protein and transcript levels were increased
in mice exposed to VILI. To provide evidence for a functional
role of MUC5AC in ALI, we subsequently exposed gene-
targeted mice for Muc5ac to ALI induced by mechanical
ventilation. Surprisingly, thesemice were profoundly protected
from lung inflammation. Additional studies pointed out that
neutrophil accumulation within the lungs ofMuc5ac / mice
were selectively attenuated, thereby implicating endogenous
production of MUC5AC in regulation of inflammatory cell
trafficking during ALI.
Similar to the present studies showing a detrimental role of
MUC5AC in ALI, previous studies show a deleterious role of
mucins in other forms of peripheral lung diseases. For example,
a recent study implicates the endogenous production of
MUC5B in the development of pulmonary fibrosis.19 Indeed,
this study identified a common variant in the MUC5B
promoter that is associated with the development of familial
interstitial pneumonia and idiopathic pulmonary fibrosis.
Linkage, fine mapping, selective re-sequencing of MUC2
and MUC5AC, and a genetic analysis of the gel-forming
mucin region at the p-terminus of chromosome 11 resulted in
the identification of a single nucleotide polymorphism
(rs35705950) in the putative MUC5B promoter that is strongly
associated with both MUC5B expression in the lung among
unaffected subjects and the development of familial interstitial
pneumonia and idiopathic pulmonary fibrosis. Moreover,
subjects with idiopathic pulmonary fibrosis had significantly
higher levels of expression of MUC5B in the lungs than did
controls, and the MUC5B protein was expressed in lesions of
idiopathic pulmonary fibrosis. As such, these studies suggest
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Figure 8 Role of Muc5ac in neutrophil transmigration in vitro. (a) Calu-3
pulmonary epithelial cells were stably transfected with hairpin siRNA
targeting MUC5AC (MUC5ACko) or non-specific control siRNA
(MUC5ACscr). Total RNA isolated and protein from cell lysates was
harvested. Left panel: MUC5AC mRNA levels were determined by real-
time reverse transcriptase–PCR. Data were calculated relative to the
internal housekeeping gene (b-actin) and are expressed as mean fold
change±s.d. compared with scramble siRNA transfection (n¼4). Right
panel: Cell lysates were probed for MUC5AC protein by enzyme-linked
immunosorbent assay. Data were normalized to protein content isolated
from MUC5ACscr cells and are expressed as mean±s.d. (n¼4).
(b) MUC5ACscr orMUC5ACko cells were seeded on an elastic membrane
and submitted to 24 h cyclic mechanical stretch. The supernatant was
harvested and transferred into the lower chamber of a transmigration
transwell system with or without a confluent Calu-3 human pulmonary
epithelial monolayer. In all, 106 freshly isolated human neutrophils (PMN)
were added to the apical chamber of the transwell. N-formyl-methionyl-
leucyl-phenylalanine (fMLP) was added to the lower chamber as PMN-
chemoattractant. (c) Transmigration over a mechanical barrier (3 mm2
pore size). After 45minutes, lower chamber was assayed for MPO activity
as readout for PMN transmigration Data are expressed as relative
changes of myeloperoxidase (MPO) activity measured by absorbance
at 405 nm (n¼ 4 per experimental condition). (d) Transmigration over
a biological barrier (confluent Calu-3 human pulmonary epithelial cell
monolayer grown on a 3 mm2 pore size insert). After 90min, basolateral
chamber was assayed for MPO activity as readout for PMN
transmigration. Data are expressed as relative changes of MPO activity
measured by absorbance at 405 nm (n¼ 4 per experimental condition).
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that overproduction of MUC5B is associated with a substan-
tially increased risk for familial interstitial pneumonia or
idiopathic pulmonary fibrosis. A possible explanation for the
relationship between the single nucleotide polymorphism and
excess production of MUC5B could be that too much MUC5B
impairs the mucosal host defense, results in excessive lung
injury from inhaled substances, and over time leads to the
development of idiopathic interstitial pneumonia.
The present studies indicate that MUC5AC levels are
transcriptionally induced during experimental lung injury.
These findings are consistent with previous studies showing
very robust increases of MUC5AC during allergic mucous
metaplasia of the surface epithelium in humans.27 By contrast,
studies of MUC5B induction during asthma demonstrate only
moderate increases.10,15,35 Indeed, several transcriptionally
controlled pathways for the regulation of MUC5AC expression
have been previously described.10 For example, recent studies
assessed the expression of the entire gel-forming mucin gene
family in allergicmouse airways and found a selective induction
ofMuc5ac. To better understand the tight regulation ofMuc5ac
expression, the authors analyzed all available 50-flanking
sequences of mammalian MUC5AC orthologs and identified
evolutionarily conserved regions within domains proximal to
the mRNA coding region. Analysis of luciferase reporter gene
activity in a mouse-transformed Clara cell line demonstrated
that this region possesses strong promoter activity and harbors
multiple conserved transcription factor-binding motifs. In
particular, SMAD4 and HIF-1a (hypoxia-inducible factor-1a)
bind to the promoter, and mutation of their recognition motifs
abolishes promoter function.14 Other studies provide evidence
that pro-inflammatory cytokines such as IL-1b and IL-17A are
potent inducers of MUC5AC mRNA and protein. MUC5AC
induction by these cytokines was both time- and dose-
dependent and occurred at the level of promoter activation,
as measured by a reporter gene assay. These effects were
attenuated by the small molecule inhibitor NF-kB inhibitor III,
as well as p65 siRNA, suggesting that the regulation of
MUC5AC expression by these cytokines is intimately linked to
NF-kB-based transcriptionalmechanisms.23 These findings are
very consistent with this study of MUC5AC expression during
a
B
A
L
B
A
L
To
ta
l i
so
la
te
d 
ce
lls
 (×
 
10
5 )
0
10
20
30
40
105
31%
105
104
104
103
103
102
102
0
105
104
103
102
0
0 1051041031020
P<0.05
Ly6G
CD
11
b
Muc5ac+/+ Muc5ac+/+ 
Muc5ac+/+  BAL Muc5ac–/– Muc5ac–/–  BALMuc5ac+/+ 
Flow cytometry Flow cytometry
b
Mechanical
ventilation  
Mechanical
ventilation  
c
Muc5ac+/+ Muc5ac–/–
PM
N
EO
S DC Mφ
19%
Figure 9 Effect of BAL fluid transfer on pulmonary granulocyte trafficking. (a) Muc5ac / mice or their corresponding littermate controls matched
in age, sex, and weight (Muc5acþ /þ ) were exposed to gentle mechanical ventilation over 3 h and bronchoalveolar lavage (BAL) fluid was collected
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cyclic mechanical stretch in vitro or during lung injury induced
by mechanical ventilation in vivo. Indeed, the present studies
implicate NF-kB-based transcriptional mechanisms in the
transcriptional regulation of MUC5AC during ALI.
Pharmacological approaches to alter the consistency of
airway mucus have been studied in ALI for many years. For
example, experimental studies implicate the mucolytic N-
acetylcysteine in the treatment of phosgene-induced lung
injury,36 lung injury following experimental lung transplanta-
tion,37 or following fat embolism.38 Although some of these
studies attribute beneficial effects of N-acetylcysteine to its
properties as antioxidant, at least some of its effects could be
related to its mucolytic effects, and improved clearance of
airway mucins. Indeed, several smaller clinical trials have
suggested treatment with N-acetylcysteine for patients suffer-
ing from ALI.39,40 Our studies implicating NF-kB in the
transcriptional induction of MUC5AC during ALI suggest that
NF-kB inhibitors would be an appropriate pharmacological
approach to dampen pulmonary MUC5AC production during
ALI. Other studies have shown a critical role of nucleotide
signaling in the secretion of mucins41 or the activation of NF-
kB. These studies implicate the nucleotide P2Y2 receptor in
nucleotide release.42 Moreover, a recent study indicates that
intracellular vesicles of Muc5ac also contain high concentra-
tions of nucleotides. Together, these findings could lead to a
feed-forward loop with release of Muc5ac, and concomitant
nucleotides release could lead to further increases ofMuc5ac via
stimulation of P2 receptors.43 Similarly, other studies have
shown that ALI is associated with the release of nucleotides,
particularly ATP.44,45 Important tissue sources for nucleotide
during ALI include pulmonary epithelia,46,47 vascular endothe-
lia,48 inflammatory cells,49,50 or platelets.51 Other studies
provide strong evidence that the A3 adenosine receptor
contributes to mucin secretion during allergic airway disease.52
As such, pharmacological inhibitors of the P2Y2 or the A3
adenosine receptor could be used as a pharmacological strategy
to dampen mucin secretion during ALI.53,54 Given that
nucleotide signaling enhances pulmonary inflammation55,56
and that MUC5AC release goes along with an increase in
extracellular nucleotides,43 it is intriguing to speculate that
MUC5AC release could contribute to lung inflammation by
increasing the concentration of nucleotides in the airway. For
example, several studies have shown that pulmonary nucleo-
tides can function as a find-me signal for inflammatory cells.57
An alternative hypothesis on how MUC5AC functions to
enhance lung inflammation could include a potential role as
cytokine ‘‘sponge’’. It is conceivable that by binding with
inflammatory cytokines and other inflammatorymediators, their
half-life in the broncho-alveolar compartment could be pro-
longed, thereby resulting in enhanced lung inflammation and
enhanced neutrophil trafficking. However, the present studies do
not yet allow a definitive conclusion on the mechanism of how
MUC5AC induces lung inflammation during ALI.
In summary, the present study provides the first in vivo
evidence that the endogenous production of MUC5AC has a
detrimental role during experimentally induced lung injury.
Indeed, the present findings implicate inhibitors of MUC5AC
induction or secretion in the treatment of ALI. Future
challenges aimed towards translating these findings from
models of VILI in mice towards the treatment of patients will
have to be directed towards further defining and examining
such pharmacological interventions.
METHODS
Cell culture. Human bronchial epithelial cells (Calu-3 or A549) were
cultured as described previously.58,59 Both cell lines express MUC5AC
as shown previously60–62
In vitro stretch model. Human bronchial epithelial cells were sub-
mitted to cyclic mechanical stretch as described previously.29 In short,
Calu-3 human bronchial epithelial cells were plated on BioFlex culture
plates collagen type I (BF-3001C; FlexCell International, Hillsborough,
NC) and allowed to attach and grow to B80% confluence. The
medium was changed to Minimum Essential Medium plus 10% fetal
bovine serum. Plates were then placed on a FlexCell FX-4000TTension
Plus System and stretched at 20% stretch maximum, 0.7% stretch
minimum, sine wave 2 s, on 2 s off. Supernatants were collected at
indicated time points, flash-frozen, and stored at  80 1C for further
analysis. In controls, supernatants from Calu-3 human epithelia
cultured under similar conditions at rest (without application of cyclic
stretch) were used. In duplicate wells, cells adherent to the plates were
used for transcriptional analysis (see below).
Murine mechanical ventilation. All animal protocols were approved
by the Institutional Animal Care andUse Committee of the University
of Colorado and are in accordance with the National Institutes of
Health guidelines for use of live animals. Mice gene-targeted for
Muc5ac16 or corresponding littermate controls were matched
according to sex, age, and weight. Muc5ac-deficient mice were
generated by the laboratory of Christopher Evans (MD Anderson
Cancer Center, Houston, TX). The correct genotype was identified by
real-time reverse transcriptase–PCR and real-time PCR. ALI was
induced with mechanical ventilation utilizing high inspiratory
pressure levels (45mbar, positive-end expiratory pressure 3mbar)
during pressure-controlled ventilation. In short, animals were
anesthetized with pentobarbital (70mg kg 1 intraperitoneally for
induction; 20mg kg 1 h 1 for maintenance) and placed on a
temperature-controlled heated table (RT, Effenberg, Munich, Ger-
many) with a rectal thermometer probe attached to a thermal feedback
controller to maintain body temperature at 37 1C. In addition, all
animals were monitored with an electrocardiogram (Hewlett Packard,
Bo¨blingen, Germany). Fluid replacement was performed with normal
saline, 0.05ml h 1 intraperitoneally Tracheotomy and mechanical
ventilation was performed as described previously.29,30 In short, the
tracheal tube was connected to a mechanical ventilator (Servo 900C,
Siemens, Germany; with pediatric tubing). Mice were ventilated in a
pressure-controlled ventilation mode at 45mbar inspiratory pressure
levels over indicated time periods. Respiratory rate and inspiratory to
expiratory time ratios (I:E ratios) were adjusted based on arterial blood
gas sampling obtained by carotid artery catheter in control animals to
maintain a carbon dioxide partial pressure between 35 and 40mmHg
and a pH between 7.35 and 7.40. For survival studies, mice were
ventilated under deep general anesthesia until a cardiac standstill was
observed in the surface electrocardiogram. All animals were ventilated
with 100% inspired oxygen. In subsets of experiments, mice were
treated with the IKK-16 (30mg kg 1 intraperitoneally, Tocris, Bristol,
UK), a highly specific inhibitor of NF-kB.32
HumanBAL samples. BAL was collected in both studies as described
previously.63 In short, 160ml in 20-ml aliquots was instilled into the
trachea with gentle suctioning after each aliquot. Samples were stored
at  80 1C for subsequent assays. After approval by the Internal
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Review Board, archived BAL samples from patients with ALI and
non-intubated, non-ventilated healthy controls were analyzed. ALI
diagnoses was established according to the American-European
Consensus Conference on ARDS.64
MUC5AC protein measurements. MUC5AC protein content was
measured utilizing custom-made ELISA.65 The semi-quantitative
measurements were performed by ElisaTech (Aurora, CO), with MS-
551-PABX (NeoMarkers, Fremont, CA) as coating antibody and MS-
145-B1 (NeoMarkers, Fremont, CA) for detection.
Microarray analysis. Transcriptional profile of human bronchiolar
epithelial cells (Calu-3) subjected to cyclic mechanical stretch (18 h)
was compared with that of unstretched cells using quantitative
genechip expression arrays as described previously.66 RNA was
isolated from cell lysates using a spin column according to manu-
facturer’s instructions (Qiagen, Germantown, MD, RNeasy mini spin
columns). Samples were analyzed using a human genome U133 Plus
2.0 array (Affymetrix, Santa Clara, CA).
Transcriptional analysis. Transcriptional changes were quantified by
microarray using a human genomeU133Plus2.0 array (Affymetrix) or
real-time reverse transcriptase–PCR (iCycler; Bio-Rad Laboratories,
Hercules, CA) as described.66,67 RNA was isolated as described
previously (Qiagen).68–70 Fold change in mRNA levels were deter-
mined as described.29,69,71 Primer sets (sense sequence and antisense
sequence, respectively) for the following genes were:Muc5ac (50-CCA
TGC AGA GTC CTC AGA ACA A-30, 50-TTA CTG GAA AGG CCC
AAGCA-30);Muc5b (50-TGT ACTGCC CCCAGGATGGGC-30, 50-
AGC TCA GCT CTG CCT GAC CCT-30);Muc2 (50-TGC CCC TGG
CTA TGACGTCTGT-30, 50-CCACCCTCCCGGCAAACACA-30);
Cxcl1 (50-CCA GAG CTT GAA GGT GTT GC-30, 50-TCT GAA CCA
AGG GAG CTT CA-30); and Cxcl2 (50-TTC ATG GAA GGA GTG
TGC AT-30, 50-ACA CGA AAA GGC ATG ACA AA-30). In case of
human cell samples, the following primer sets were used: MUC5AC
(50-CAG CCA CGT CCC CTT CAA TA-30, 50-ACC GCA TTT GGG
CAT CC-30). Each target sequence was amplified using increasing
numbers of cycles of 94 1C for 1min, 58 1C for 0.5min, 72 1C for 1min.
-actin mRNA (murine: sense primer, 50-ACA TTG GCA TGG CTT
TGT TT-30 and antisense primer, 50-GTT TGC TCC AAC CAA CTG
CT-30; human: sense primer, 50-GGT GGC TTT TAG GAT GGC
AAG-30 and antisense primer, 50-ACT GGA ACG GTG AAG GTG
ACA G-30) was amplified in identical reactions to control for the
amount of starting template. Levels and fold change in mRNA were
determined as described previously.29,69,71
PCR-Array. In a subset of experiments, the expression of different
chemokines and cytokines and their corresponding receptors
were analyzed. RNA was isolated from control animals and mice
submitted to VILI, followed by extraction of total RNA using
RNeasy mini spin columns (Qiagen). Gene expression was examined
with the mouse RT2 profiler PCR arrays (PAMM-11; SABiosciences,
Frederick, MD) using cDNA (Reaction Ready First-Strand
cDNA Synthesis kit; SABiosciences). Fold changes in gene expression
were calculated in mice submitted to VILI relative to control
animals with the same genotype (Muc5acþ /þ -VILI vs.Muc5acþ /þ -
Control and Muc5ac / -VILI vs. Muc5ac / -Control). The
software for this calculation was provided by the manufacturer
of the PCR-Array (http://www.sabiosciences.com/pcr/arrayanalysis.
php).
Immunohistochemistry. To examine the influence of mechanical
ventilation on pulmonary Muc5ac expression, mice were ventilated in
a pressure-controlled fashion over indicated time periods. Mice were
euthanized, and the lungs were perfused via the right ventricle with
5ml of phosphate-buffered saline. Lungs were subsequently removed
and stained with chicken anti-mouse polyclonal Muc5ac antibody as
described previously.72 Preimmune sera and control tissue were used
at identical concentrations and staining conditions as the target
primary antibodies. As secondary, a goat anit-chicken antibody was
used (AlexaFluor 488, Invitrogen, Grand Island, NY).
BALinmice. To obtain BAL fluid from experimentalmice, the tracheal
tube was disconnected from the mechanical ventilator, and the lungs
were lavaged three times with 0.5ml of phosphate-buffered saline. All
removed fluid was centrifuged immediately and the supernatant was
aliquoted for measurement of albumin concentration.
Protein analysis. MPO, Cxcl1, and IL-6 content of the murine lung
were quantified by ELISA (R&D Systems, Minneapolis, MN), then
normalized to total protein content of the sample. Albumin content of
bronchoalveolar lavage (BAL) was determined by ELISA (Bethyl,
Montgomery, TX). After approval by the IRB, MUC5AC protein was
measured in BAL samples from patients with ALI and non-ventilated
controls utilizing semi-quantitative ELISA by ElisaTech (Aurora, CO).
Wet-to-dry ratios. Wet-to-dry ratios were measured as previously
described.73,74 In short, following ventilation with indicated settings,
lungs were excised en bloc. The weight was obtained immediately to
prevent evaporative fluid loss of the tissues. Lungs were then lyo-
philized for 48 h, and the dry weight was measured. Wet-to-dry ratios
were then calculated as mg water per mg of dry tissue.
Blood gas analysis. To assess pulmonary gas exchange, blood gas
analyses were performed in subsets of experiments by obtaining
arterial blood via a carotid artery catheter as described previously.75,76
Analysis was performed immediately after collection with the I-STAT
analyzer (Abbott, Abbott Park, IL) and the arterial partial pressure of
oxygen (PaO2) was measured, in addition to arterial partial carbon
dioxide pressure and pH-values.
Histopathological evaluation of ALI. Following ventilation at
indicated settings, the mice were euthanized and lungs were fixed by
instillation of 10% formaldehyde solution via the tracheal cannula at a
pressure of 20mbar. Lungs were then embedded in paraffin and
stainedwith hematoxylin and eosin or Alcian blue/periodic acid-Schiff
staining. Two random tissue sections from four different lungs in each
groupwere examined by an investigatorwhowas blinded to the genetic
background/treatment of the mice. For each subject (alveolar
congestion, hemorrhage, neutrophil aggregation, and hyline mem-
branes), a five-point scale was applied: 0¼minimal (little) damage,
1þ ¼mild damage, 2þ ¼moderate damage, 3þ ¼ severe damage,
and 4þ ¼maximal damage. Points were added up and are expressed
as median±s.d. (n¼ 4)28 (see Supplementary Table S3 online).
Flow cytometry of pulmonary tissue and BAL. After harvest of BAL
fluid, the lungs were excised. Tissue was digested with collagenase VIII
(Sigma Aldrich, St Louis, MO), filtered, and viability assessed before
staining. Cells from indicated compartments were incubatedwith anti-
mouse Fc-block (CD16/32: clone 93; eBioscience, San Diego, CA) and
fluorescently labeled antibodies against: Siglec-F (clone E50-2440; BD
Biosciences, San Jose, CA); CD11c (clone N418), Ly6G (clone 1A8;
Biolegend, San Diego, CA); MHCII (clone M5/114.15.2), CD45.2
(clone 104), CD11b (clone M1/70), F4/80 (clone BM8) (eBioscience);
or corresponding isotype controls. Live cells were acquired using
a LIVE/DEAD fixable aqua dead cell stain (Invitrogen). Cells were
washed and fixed with 1% paraformaldehyde and analysed using
a FACS Canto system (Beckton-Dickinson Immunocytometry
Systems, San Jose, CA). Post analyses were performed using FLOWJo
software (Tree Star, Ashland, OR). Percentage of live CD45þ cells of
each population were calculated and multiplied by the total cell
number retrieved from organ harvest to calculate actual cell number of
distinct sub-populations.
MUC5AC suppressionwith RNA interference. Calu-3 were grown in
60-mm Petri dishes. Different sets of siRNA directed against human
MUC5AC were designed using standard molecular tools, synthesized
by InVivogen (San Diego, CA), and tested with reverse transcriptase–
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PCR for their efficiency to suppress MUC5AC expression at different
concentrations. Highest efficiencies were found with 50-ACCTCG
TGTCAAAGTGTGCCTGCGTCTACATCAAGAGTGTAGACGCA
GGCACACTTTGACACTTdTdT-30. As non-specific control, the
sense strand of the MUC5AC oligoribonucleotide was used under
identical conditions. Calu-3 loading was accomplished using standard
conditions of Fugene6 (Roche Diagnostics, Indianapolis, IN), when
cells had reached 40–60% confluence.
In vitro PMN transmigration. Isolation of human PMNs was per-
formed by Histopaque 1077 gradient as described.33,77 In all, 1 106
PMNwere added to the insert of a Transwell plate (6.5 polyester, 3 mm
pore size; Costar, Tewksbury, MA) chamber in the presence of
supernatant from cells that were transfected with a siRNA directed
against MUC5AC (MUC5ACKO) or a control siRNA (MUC5ACscr).
Formyl-methinyl-leucyl-phenylalanine (Sigma Aldrich) was added at
a final concentration of 1 mM to the lower chamber.78 In a subset of
experiments, Calu-3 pulmonary epithelial cells were cultured on
inverted 6.5mm polyester permeable Transwell membranes (3.0 mm
pore;Costar) as an additional barrier as previously described.33 The
assay was incubated at 37 1C for 45mins, when no cell barrier was
present and for 1.5 h in the presence of a cell barrier. Numbers of
transmigrated PMNwere determined byMPO assay, as described.33,79
Data analysis. All data are presented as mean±s.d. from 4–6 animals
per condition. We performed statistical analysis using Student’s t-test
(two sided, ao0.05) or analysis of variance to determine group
differences. To test survival differences, we used the Mantel–Cox test.
Po0.05 was considered statistically significant.
SUPPLEMENTARYMATERIAL is linked to the online version of the paper
at http://www.nature.com/mi
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